Skip to main content
Log in

Prognostische Bedeutung immunhistochemischer Untersuchungen

  • Im Fokus
  • Published:
HNO Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Innocente SA, Abrahamson JLA, Cogswell JP, Lee JM (1999) p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci 96: 2147–2152

    CAS  PubMed  Google Scholar 

  2. Morris EJ, Dyson NJ (2001) Retinoblastoma protein partners. Adv Cancer Res 82: 1–54

    CAS  PubMed  Google Scholar 

  3. Nickels A, Bureik M, Montenarh M, Pfreundschuh M, Koch B (1997) p53 antibodies:call for quality. Int J Cancer 73: 613–614

    CAS  PubMed  Google Scholar 

  4. Nickels A, Selter H, Montenarh M, Pfreundschuh M, Koch B (1997) Detection of p53 in inflammatory tissue and in lymphocytes by immunohistochemistry and flow cytometry- a critical comment. J Clin Pathol 50: 654–660

    CAS  PubMed  Google Scholar 

  5. Otterson GA, Kratzke RA, Coxon A, Kim YW, Kaye FJ (1994) Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9: 3375–3378

    CAS  PubMed  Google Scholar 

  6. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323–330

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Montenarh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montenarh, M. Prognostische Bedeutung immunhistochemischer Untersuchungen. HNO 51, 787–789 (2003). https://doi.org/10.1007/s00106-003-0957-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00106-003-0957-0

Navigation